Virology Unit and Bioinformatics Centre, Institute of Microbial Technology, Council of Scientific and Industrial Research (CSIR), Sector 39-A, Chandigarh 160036, India.
Database (Oxford). 2020 Jan 1;2020. doi: 10.1093/database/baz159.
Nipah virus (NiV) is an emerging and priority pathogen from the Paramyxoviridae family with a high fatality rate. It causes various diseases such as respiratory ailments and encephalitis and poses a great threat to humans and livestock. Despite various efforts, there is no approved antiviral treatment available. Therefore, to expedite and assist the research, we have developed an integrative resource NipahVR (http://bioinfo.imtech.res.in/manojk/nipahvr/) for the multi-targeted putative therapeutics and epitopes for NiV. It is structured into different sections, i.e. genomes, codon usage, phylogenomics, molecular diagnostic primers, therapeutics (siRNAs, sgRNAs, miRNAs) and vaccine epitopes (B-cell, CTL, MHC-I and -II binders). Most decisively, potentially efficient therapeutic regimens targeting different NiV proteins and genes were anticipated and projected. We hope this computational resource would be helpful in developing combating strategies against this deadly pathogen. Database URL: http://bioinfo.imtech.res.in/manojk/nipahvr/.
尼帕病毒(NiV)是副黏病毒科的一种新兴且优先考虑的病原体,具有很高的致死率。它会引起各种疾病,如呼吸道疾病和脑炎,对人类和家畜构成巨大威胁。尽管进行了各种努力,但目前尚无批准的抗病毒治疗方法。因此,为了加快和协助研究,我们开发了一个综合性资源 NipahVR(http://bioinfo.imtech.res.in/manojk/nipahvr/),用于针对 NiV 的多靶向假定治疗药物和表位。它分为不同的部分,即基因组、密码子使用、系统发育基因组学、分子诊断引物、治疗药物(siRNA、sgRNA、miRNA)和疫苗表位(B 细胞、CTL、MHC-I 和 -II 结合物)。最重要的是,预计和预测了针对不同 NiV 蛋白和基因的潜在有效治疗方案。我们希望这个计算资源有助于开发针对这种致命病原体的对抗策略。数据库网址:http://bioinfo.imtech.res.in/manojk/nipahvr/。